Main Menu
Menu

Resources

Publish Date
Resources
Letters
C4IP Letter to USTR on US-EU Trade Agreement, 12/4/2025
Resources
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Resources
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Resources
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
C4IPResources
Letters
C4IP Letter to Senate and House IP Subcommittees on Designating October as National IP Month

Dear Chairmen Tillis and Issa and Ranking Members Schiff and Johnson: On behalf of the Council for Innovation Promotion (C4IP), I write...

Resources
Letters
C4IP Letter to Senate Judiciary IP Subcommittee on PERA Hearing
Resources
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Resources
Letters
C4IP Letter to House Judiciary IP Subcommittee on Artificial Intelligence
Resources
Letters
C4IP Letter to FTC & DOJ on Drug Pricing Listening Sessions
Resources
Infographics & Fact Sheets
Drug Competition Enhancement Act Infographic
Resources:

Resources:

C4IP Comments RE: Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights,

02/06/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary IP Subcommittee on PERA,

02/06/2024
Resources:

Resources:

Former Commerce Officials Letter to President Biden on March-in Rights,

02/02/2024
Resources:

Resources:

C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement,

01/30/2024
Resources:

Resources:

C4IP Comments RE: Special 301 Review,

01/30/2024
Resources:

Resources:

C4IP Letter to EU Parliament on Proposed EU SEP Regulation,

01/23/2024
Resources:

Resources:

C4IP Comments RE: WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (PTO-C-2023-0019),

01/22/2024
Resources:

Resources:

The Bayh-Dole Act and March-In Rights,

12/08/2023
Resources:

Resources:

C4IP Letter to President Biden on Covid-19 IP Waiver Proposal,

12/04/2023
Resources:

Resources:

C4IP Letter to Senate Judiciary IP Subcommittee Chairman Coons and Ranking Member Tillis on PREVAIL Act Hearing,

11/07/2023
Resources:

Resources:

C4IP Comments RE: Joint ITA-NIST-USPTO Collaboration Initiative Regarding Standards (PTO-C-2023-0034),

11/06/2023
Resources:

Resources:

C4IP Letter to Secretary Becerra and Secretary Raimondo on Bayh-Dole Interagency Working Group Report,

10/25/2023
Scroll to Top